APA ציטוט

OKITA, R., SHIMIZU, K., NOJIMA, Y., YUKAWA, T., MAEDA, A., SAISHO, S., & NAKATA, M. (2015). Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells. Oncol Rep.

Citação norma Chicago

OKITA, RIKI, KATSUHIKO SHIMIZU, YUJI NOJIMA, TAKURO YUKAWA, AI MAEDA, SHINSUKE SAISHO, and MASAO NAKATA. "Lapatinib Enhances Trastuzumab-mediated Antibody-dependent Cellular Cytotoxicity Via Upregulation of HER2 in Malignant Mesothelioma Cells." Oncol Rep 2015.

ציטוט MLA

OKITA, RIKI, et al. "Lapatinib Enhances Trastuzumab-mediated Antibody-dependent Cellular Cytotoxicity Via Upregulation of HER2 in Malignant Mesothelioma Cells." Oncol Rep 2015.

אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.